ADIPOQ and Insulin resistance: This coupled with biochemical indicators such as high levels of inflammatory markers, low levels of adiponectin, the coexistence of hyperinsulinemia, insulin resistance, hypertriglyceridemia, abnormal lipid profiles, endothelial dysfunction, and hyperhomocystenemia sets the stage for chronic low-grade inflammation that exacerbates morbidity and mortality.